Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions.
Stüve O, Marra CM, Cravens PD, Singh MP, Hu W, Lovett-Racke A, Monson NL, Phillips JT, Tervaert JW, Nash RA, Hartung HP, Kieseier BC, Racke MM, Frohman EM, Hemmer B.
Stüve O, et al.
Arch Neurol. 2007 Feb;64(2):169-76. doi: 10.1001/archneur.64.2.169.
Arch Neurol. 2007.
PMID: 17296831
Review.